Literature DB >> 18129784

Effective penicillin therapy in subacute bacterial endocarditis and other chronic infections.

J G SCHLICHTER, H MacLEAN, A MILZER.   

Abstract

Entities:  

Keywords:  ENDOCARDITIS/infection; PENICILLIN/therapy

Mesh：

Substances：

Year:  1949        PMID： 18129784     DOI： 10.1097/00000441-194906000-00002

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  7 in total

Review 1.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

2.  Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.

Authors:  Stellah G Mpagama; Norah Ndusilo; Suzanne Stroup; Happiness Kumburu; Charles A Peloquin; Jean Gratz; Eric R Houpt; Gibson S Kibiki; Scott K Heysell
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

3.  Serum bactericidal titer as a predictor of outcome in endocarditis.

Authors:  C J Hackbarth; H F Chambers; M A Sande
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

4.  Indications, interpretation and applications of antibiotic assays.

Authors:  E Yourassowsky
Journal:  Infection       Date:  1978       Impact factor: 3.553

Review 5.  Technical aspects and clinical correlations of the serum bactericidal test.

Authors:  H C Standiford; B A Tatem
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

6.  Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases.

Authors:  Eric Gomez; Martha Sanchez; Zonaira Gul; Carl Urban; Noriel Mariano; Robert H K Eng; David B Huang; Tom Chiang
Journal:  Case Rep Med       Date:  2011-11-28

7.  Improvement in plasma drug activity during the early treatment interval among Tanzanian patients with multidrug-resistant tuberculosis.

Authors:  Norah D Ndusilo; Scott K Heysell; Stellah G Mpagama; Jean Gratz; Farida H Segesela; Saumu J Pazia; Xin-Qun Wang; Eric R Houpt; Gibson S Kibiki
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.